Start Date
October 31, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Tirbanibulin
subjects receive 2,5 mgTirbanibulin in 250 mg ointment with daily administration of one single sachet on the left hand and 250mg ointment placebo on the right hand for 5 d in a single-blinded manner.
Collaborators (1)
Almirall, SAS
INDUSTRY
Medical University of Graz
OTHER